MOXAYI CV 625 is a combination antibiotic formulation containing Amoxicillin and Potassium Clavulanate, designed to effectively treat a wide range of bacterial infections. This advanced dual-action therapy combines the proven antibacterial activity of Amoxicillin with the resistance-fighting properties of Clavulanic Acid, providing enhanced protection against susceptible bacteria.

Amoxicillin works by preventing the formation of bacterial cell walls, which are essential for bacterial growth and survival. Potassium Clavulanate acts as a beta-lactamase inhibitor, helping protect Amoxicillin from bacterial enzymes that can reduce its effectiveness. This combination enhances the antibiotic’s activity and broadens its spectrum of action against resistant bacteria.

Key Benefits

• Effective against a wide range of bacterial infections.
• Helps overcome bacterial resistance mechanisms.
• Provides enhanced antibacterial protection.
• Supports faster recovery from infection-related symptoms.
• Broad-spectrum antibiotic coverage.
• Helps reduce the risk of treatment failure due to resistant bacteria.

Therapeutic Uses

MOXAYI CV 625 Tablets are commonly prescribed for the treatment of:

Respiratory Tract Infections

• Sinusitis
• Tonsillitis
• Pharyngitis
• Bronchitis
• Pneumonia

Ear, Nose & Throat Infections

• Ear Infections (Otitis Media)
• Throat Infections
• Sinus Infections

Urinary Tract Infections (UTIs)

• Bacterial infections affecting the urinary system.

Skin & Soft Tissue Infections

• Skin infections
• Wound infections
• Soft tissue bacterial infections

Dental Infections

• Tooth abscesses and other bacterial dental conditions.

Bone & Joint Infections

• Certain bacterial infections affecting bones and joints as advised by a healthcare professional.

How It Works

Amoxicillin
A penicillin-class antibiotic that kills bacteria by interfering with the formation of their protective cell walls.

Potassium Clavulanate
A beta-lactamase inhibitor that prevents bacteria from deactivating Amoxicillin, thereby enhancing its effectiveness against resistant bacterial strains.

Composition

• Amoxicillin IP
• Potassium Clavulanate IP
• Equivalent to MOXAYI CV 625

Important Information

MOXAYI CV 625 is effective only against bacterial infections and should not be used for viral illnesses such as the common cold or influenza.

MOXAYI CV 625 Tablets provide reliable, broad-spectrum antibacterial therapy for effective infection management and improved patient outcomes.